CRP and obesity due to melanocortin 4 receptor deficiency: However, enterolactone urinary levels were associated with reduced obesity, reduced C-reactive protein, reduced blood pressure, reduced triglycerides, higher serum–HDL-cholesterol, and a lower occurrence of metabolic syndrome.